首页> 美国卫生研究院文献>Signal Transduction and Targeted Therapy >NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells
【2h】

NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells

机译:NT157具有抗肿瘤作用并抑制JAK2V617F阳性骨髓增生性肿瘤细胞中的IRS1 / 2和STAT3 / 5

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cell viability was determined by methylthiazole tetrazolium (MTT) assays for HEL cells with or without NT157 treatment (0.2, 0.4, 0.8, 1.6, and 3.2 µM) for 24, 48, and 72 h. Bar graphs represent the mean ± SD of at least three independent experiments, and the dots represent the value of each experiment; ***  b Apoptosis was detected by flow cytometry in HEL cells with or without NT157 treatment (0.2, 0.4, 0.8, and1.6 µM) for 24, 48, and 72 h using an annexin V/PI staining method. Bar graphs represent the mean ± SD of at least three independent experiments where annexin V-positive cells were quantified, and the dots represent the value of each experiment; **  p c Representative flow cytometry dot plots are shown for each condition; the upper and lower right quadrants cumulatively contain the apoptotic population (annexin V-positive cells). Caspases 3, 8, and 9 levels (total and cleaved) were assessed by western blot analysis in total cell extracts from HEL with NT157 treatment (Ø, 0.2, 0.4, 0.8, 1.6, and 3.2 µM) for 24 h; membranes were reprobed with antibodies to detect total target protein and/or actin, and then they were developed with a SuperSignal™ West Dura Extended Duration Substrate system and a Gel Doc XR + system. Ki-67 mean fluorescence intensity (MFI) was determined by flow cytometry after incubation of HEL cells with NT157 (Ø, 0.2, 0.4, 0.8, 1.6, and 3.2 µM) for 24 h; bar graphs represent the Ki-67 MFI normalized to the respective untreated control cells, and the results are shown as the mean ± SD of three independent experiments. The dots represent the value of each experiment; **  p f Histograms show Ki-67 MFI peaks for all tested conditions. Each condition is represented by one color that is defined in the legend located in the left panel. Colonies containing viable cells were detected by MTT assay after 10 days of culture with NT157, and data are normalized to the corresponding untreated control. Colony images are shown for one experiment, and the bar graphs show the mean ± SD of five independent experiments. The dots represent the value of each experiment; *  h Cell cycle progression was determined by a BD Cycletest™ Plus DNA Reagent Kit in HEL cells treated with NT157 (Ø, 0.2, 0.4, and 0.8 µM) for 24 h. A representative histogram for each condition is illustrated; cell cycle phases are detected based on DNA quantity: blue (cells in G /G ), green (cells in S), and pink (G /M cells). Bar graphs represent the mean ± SD of the percent of cells in the G /G , S, and G /M phase of three independent experiments; **  p
机译:通过甲基噻唑四唑鎓(MTT)测定法对经过或未经过NT157处理(0.2、0.4、0.8、1.6和3.2μM)24、48和72h的HEL细胞的细胞活力进行了测定。条形图表示至少三个独立实验的平均值±SD,点表示每个实验的值; *** b通过膜联蛋白V / PI染色法,流式细胞术检测经过或不经过NT157处理(0.2、0.4、0.8和1.6μM)24、48和72μh的HEL细胞的凋亡。柱状图表示至少三个独立实验的平均值±SD,其中量化膜联蛋白V阳性细胞,点表示每个实验的值。 ** p c显示每种情况下的代表性流式细胞术点图;右上象限和右下象限累计包含凋亡种群(膜联蛋白V阳性细胞)。通过蛋白质印迹分析,用NT157处理(Ø,0.2、0.4、0.8、1.6和3.2μm)的HEL的总细胞提取液24小时,评估了胱天蛋白酶3、8和9的水平(总的和裂解的)。用抗体对膜进行探测,以检测总的靶蛋白和/或肌动蛋白,然后用SuperSignal™West Dura延伸底物底物系统和Gel Doc XR +系统进行显影。将HEL细胞与NT157(Ø,0.2、0.4、0.8、1.6和3.2μm)孵育24 h后,通过流式细胞术测定Ki-67平均荧光强度(MFI)。柱状图代表相对于未处理的对照细胞标准化的Ki-67 MFI,结果显示为三个独立实验的平均值±SD。点代表每个实验的值; ** p f直方图显示了所有测试条件下的Ki-67 MFI峰。每个条件都由左侧面板中图例中定义的一种颜色表示。用NT157培养10天后,通过MTT测定法检测含有活细胞的菌落,并将数据归一化至相应的未处理对照。显示了一个实验的菌落图像,条形图显示了五个独立实验的平均值±SD。点代表每个实验的值; * h细胞周期进程由BD Cycletest™Plus DNA试剂盒测定,用NT157(Ø,0.2、0.4和0.8 µM)处理24 h的HEL细胞。说明了每种情况的代表性直方图;根据DNA量检测细胞周期阶段:蓝色(G / G中的细胞),绿色(S中的细胞)和粉红色(G / M细胞)。条形图表示三个独立实验在G / G,S和G / M阶段的细胞百分比的平均值±SD。 ** p

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号